Table 5.

Set of examinations to be performed at the end of treatment of each patient with PTB

Clinical assessment	Clinical history Symptom assessment Clinical examination
Imaging	Chest radiography Computed tomography if chest radiography is severely abnormal or low dyspnoea score
Microbiological evaluation	If available Sputum specimen for smear microscopy and mycobacterial culture – DST if culture-positive (if possible)
Subjective evaluation	Dyspnoea score
Functional evaluation (if dyspnoea is present)	Six-minute walk test Spirometry Body plethysmography Diffusion capacity assessment (DLCO, KCO) Tidal volume Pulse oximetry Arterial blood gas analysis in case of low peripheral oxygen saturation Cardiopulmonary exercise testing
Plan a follow-up 6 months after TB treatment completion (to evaluate for relapse, bronchiectasis, persisting opacification or nodules which might indicate need for rehabilitation)

PTB = pulmonary TB; DST = drug susceptibility testing; DLCO = diffusing capacity for carbon monoxide; KCO = carbon monoxide transfer coefficient.